Status:
COMPLETED
Hypnosis for Patients Treated With Adjuvant Chemotherapy for Breast Cancer(HYPNOVAL)
Lead Sponsor:
Institut du Cancer de Montpellier - Val d'Aurelle
Conditions:
Breast Cancer
Eligibility:
FEMALE
18+ years
Phase:
NA
Brief Summary
The main objective is to assess the feasibility of an intervention based on medical Ericksonian hypnosis as a complementary therapy in patients treated with surgery after a diagnosis of breast cancer,...
Detailed Description
In the field of management of cancer, many approaches have been used since tens of years, particularly in regard of pain management, both in achieving surgical or invasive procedures in the pain induc...
Eligibility Criteria
Inclusion
- • Female, age \> 18 years-old
- Without previous practice of hypnosis
- Patient with diagnosis of breast cancer
- Patient receiving an adjuvant chemotherapy for at least 3 months with an indication of radiotherapy after chemotherapy
- Patient accepting the principle of the study with a signed written informed consent
- Patient affiliated to French Social Security
Exclusion
- • Male
- Age \< 18 years
- Patient refusing hypnosis
- Pregnancy, breast-feeding, or lack of effective contraception in female patients with reproductive potential.
- Patient with psychological or mental disorders under psychotropic treatments (lithium, neuroleptics)
- Not ability to speak and read French, deaf and/or mute
Key Trial Info
Start Date :
July 1 2015
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
June 6 2017
Estimated Enrollment :
35 Patients enrolled
Trial Details
Trial ID
NCT03250130
Start Date
July 1 2015
End Date
June 6 2017
Last Update
August 10 2020
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Institut régional du Cancer de montpellier
Montpellier, France, 34298